# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Leonardo da Vinci (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE001-SYN-TD
- Date: 1517-10-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Beatrice Carrow-Asante, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Nine-week review of the ulnar neuropathy and lipids; decision about surgery. **S**

## History of present illness

Mr. da Vinci returns nine weeks after the diagnosis, about fifteen weeks after the fall. He has worn both splints faithfully and has had fourteen sessions of hand therapy. The numbness of the little finger is much less. His grip is a little stronger, but the ring and little fingers still curl when he reaches for a brush, and he still cannot hold the palette in his right hand for more than a few minutes; fine brushwork with the right hand is beyond him. He draws, writes, and teaches every day with his left hand and paints small panels with a palette fixed to the easel and built-up brushes, with an assistant mixing colors. He takes atorvastatin each evening without muscle aches. He has had no further falls. **S**

| Element | Detail |
|---|---|
| Splints and therapy | Both splints worn; fourteen hand-therapy sessions |
| Symptoms | Numbness much less; grip slightly stronger; clawing persists |
| Function | Drawing, writing, and teaching with the left hand; painting small panels with adapted tools |
| Statin | Nine weeks; no muscle aches |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Neurological | Positive | Little-finger numbness much improved; persistent weakness of the right hand; no new symptoms |
| Musculoskeletal | Negative | No muscle aches; no elbow pain |
| Cardiovascular | Negative | No chest pain or palpitations |

3 systems reviewed. **S**

## Current medications

- Atorvastatin 20 mg oral tablet, one tablet by mouth each evening **S**

## Allergies

- No known allergy **S**

## Objective

BP 124/74 mmHg; pulse 66 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 98% on room air; weight 73.6 kg; BMI 24 kg/m². All vital signs are synthetic.

Total cholesterol: 158 mg/dL; HDL cholesterol: 51 mg/dL; LDL cholesterol: 82 mg/dL; Triglycerides: 124 mg/dL. All results are synthetic.

## Change since baseline

- Total cholesterol: 222 mg/dL (high) at baseline, 158 mg/dL at this visit **S**
- HDL cholesterol: 49 mg/dL at baseline, 51 mg/dL at this visit **S**
- LDL cholesterol: 146 mg/dL (high) at baseline, 82 mg/dL at this visit **S**
- Triglycerides: 135 mg/dL at baseline, 124 mg/dL at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| Right hand | Two-point discrimination 6 mm at the little finger; first dorsal interosseous 3+/5, abductor digiti minimi 4-/5, deep flexor of the little finger 4+/5; Froment sign still positive; clawing of the ring and little fingers persists; first web wasting unchanged |
| Right elbow | Tinel sign weaker; elbow flexion test positive at 45 seconds; nerve does not sublux |
| Cardiovascular | Blood pressure 124/74 mmHg; regular pulse |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Ulnar neuropathy at the right elbow (cubital tunnel), post-traumatic** (G56.21). About fifteen weeks after the injury, sensation has largely recovered (two-point discrimination 10 to 6 mm) but intrinsic weakness and clawing persist (first dorsal interosseous 3/5 to 3+/5; grip 20 to 24 kg against 38 kg on the left; QuickDASH 52 to 41). AAOS guidance advises surgery when nonsurgical treatment has not improved the condition or when compression has caused muscle weakness, and lost muscle may not recover if decompression is delayed. In shared decision-making, with Dr. Lindqvist-Obi's advice, he chose surgery now rather than three more months of splinting. **S**
   - In situ decompression of the ulnar nerve at the right elbow, booked with Dr. Lindqvist-Obi in three weeks; anterior transposition only if the nerve subluxes at operation.
   - Expected course explained: sensation and pain usually improve first; strength may recover over months and may not fully return.
   - Tendon transfers for the claw only if it persists a year or more after decompression.
   - Continue the anti-claw splint, the elbow pad, and hand therapy until surgery; he keeps working with his left hand.
2. **Primary hypercholesterolemia** (E78.00). LDL 82 mg/dL from 146 (44 percent lower) on atorvastatin 20 mg, within the 30 to 49 percent reduction expected of a moderate-intensity statin; no muscle symptoms. **S**
   - Continue atorvastatin 20 mg.
   - Lipid panel in a year once stable.
3. **History of falling** (Z91.81). No further falls; handrail and lighting in place. **S**
   - Review at each visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Ulnar motor and sensory examination: strength of the first dorsal interosseous, abductor digiti minimi, and deep flexor of the little finger (MRC grade), two-point discrimination of the little finger, Froment and Wartenberg signs, clawing, and wasting | Every visit during treatment | Completed today | Two-point discrimination 6 mm at the little finger; first dorsal interosseous 3+/5, abductor digiti minimi 4-/5, deep flexor 4+/5; clawing persists |
| Examination | Grip and key-pinch dynamometry, both hands | Every visit during treatment | Completed today | Grip 24 kg right, 38 kg left; key pinch 3.8 kg right |
| Survey | Patient-reported hand function (QuickDASH) | Before treatment, then at each review | Completed today | 41 of 100, from 52 |
| Self-management | Splint use and avoiding pressure on and prolonged bending of the elbow | Every visit during treatment | Completed today | Both splints worn; elbow pad in use |
| Referral | Hand therapy | Twice a week from diagnosis | Completed today | Fourteen sessions; continues until surgery |
| Referral | Surgical review at about three months for persistent weakness | At about three months from the injury | Completed today | Decompression chosen and booked |
| Medication safety | Corticosteroid injection at the cubital tunnel | Not part of treatment | Not indicated | No benefit over placebo at three months in the Cochrane review |
| Laboratory | Lipid panel after starting a statin | 4 to 12 weeks after starting or changing | Completed today | LDL 82 mg/dL, 44 percent below baseline; total cholesterol 158, HDL 51, triglycerides 124 mg/dL |
| Laboratory | ALT on a statin | Baseline only; then if symptoms | Not indicated | Normal at baseline; no symptoms |
| Medication safety | Statin adherence and muscle symptoms | Every visit | Completed today | No missed doses; no muscle aches |
| Examination | Blood pressure, weight, and smoking status | Every visit | Completed today | 124/74 mmHg; 73.6 kg; never smoker |

## Goal progress

- Stroke excluded and the lesion localized by the second visit. Outcome by 1517-08-17: Normal neurological examination apart from the right ulnar territory; MRI brain normal; nerve conduction studies, EMG, and ultrasound confirm ulnar neuropathy at the elbow. **S**
- Keep working: drawing, writing, and teaching with the left hand, and painting with adapted tools and help. In progress; target 1518-02-01. **S**
- Recovery of ulnar sensation and intrinsic strength, judged at about three months from the injury. In progress; target 1518-02-01. **S**
- LDL down by 30 to 49 percent on a moderate-intensity statin. Outcome by 1517-10-20: LDL 146 to 82 mg/dL (44 percent) after nine weeks of atorvastatin 20 mg. **S**
- No further falls. In progress; target 1518-08-01. **S**

## Guideline basis

- Cubital Tunnel Syndrome (Ulnar Nerve Entrapment at the Elbow), OrthoInfo (2026), American Academy of Orthopaedic Surgeons
- Treatment for ulnar neuropathy at the elbow (Caliandro P, et al.) (2025), Cochrane Database of Systematic Reviews
- Practice parameter for electrodiagnostic studies in ulnar neuropathy at the elbow: summary statement (American Association of Electrodiagnostic Medicine, American Academy of Neurology, American Academy of Physical Medicine and Rehabilitation) (1999), Muscle & Nerve
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018), American Heart Association / American College of Cardiology (Circulation)
- CMID: Clinical Monitoring Intelligence Database, hyperlipidemia monograph (2026), Aether Forge

## Follow-up

- Surgery in three weeks; post-operative review with the hand surgeon at two weeks and primary care review after that; lipid panel in a year. **S**

